EARNINGS (LOSS) PER SHARE - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common stock instruments outstanding (in shares)	1,819	1,276	1,939	1,276
Shares issuable upon the release of RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common stock instruments outstanding (in shares)	1,193	462	1,313	462
Shares issuable upon exercise of stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common stock instruments outstanding (in shares)	379	567	379	567
Shares issuable upon the exercise of the Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common stock instruments outstanding (in shares)	247	247	247	247